Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Placebo-controlled, Single-center Study of the Efficacy and Safety of BIO-K+ CL-1285® in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection
Conditions
Interventions
BIO-K+ CL-1285®
Placebo
Start Date
December 1, 2008
Primary Completion Date
March 1, 2009
Completion Date
April 1, 2009
Last Updated
March 13, 2012
NCT07234448
NCT03181516
NCT06665503
NCT05607056
NCT04212403
NCT00182429
Lead Sponsor
Bio-K Plus International Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions